
Enhabit, Inc.
Enhabit, Inc. (EHAB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EHAB · as of Jun 9, 2026
Key Statistics
Explore Enhabit, Inc. Data
ehab stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 11 · Buy rate: 18.2%
The EHAB analyst consensus is Hold, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $13.53, representing -1.96% downside from the current price of $13.80.
Competitors & Peers
ehab competitorsStock Performance
Full HistoryAbout Enhabit, Inc.
Enhabit, Inc. operates as a U.S.-based provider of home healthcare and hospice services. Its comprehensive home health division offers various services, such as patient education, pain management, wou…
what is enhabit, inc. · ehab stock overview · enhabit, inc. company profile · who is enhabit, inc. ceo · ehab NYSE · enhabit, inc. headquarters · enhabit, inc. business segments
About Stock Overview & Key Data
Enhabit, Inc. (EHAB) is a Healthcare company in the Medical - Care Facilities industry, listed on NYSE since Jun 23, 2022. As of the latest trading session, EHAB stock price is $13.80, with a market capitalization of $706.9M. The stock has returned +28.01% over the past 12 months and +49.67% year-to-date.
According to 11 Wall Street analysts, the consensus rating for Enhabit, Inc. stock is Hold, with an average 12-month price target of $13.53. In fiscal year 2025, Enhabit, Inc. reported revenue of $1.1B and net income of -$4.6M. For detailed data — including Enhabit, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Enhabit, Inc. (EHAB) stock price is $13.80. The stock is traded on NYSE under the ticker symbol EHAB. The 52-week range is $6.47 – $14.22.